IQVIA Holdings Inc. (0JDM.L)
| Previous close | 235.23 |
| Open | 235.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 231.84 - 236.45 |
| 52-week range | 166.94 - 261.42 |
| Volume | |
| Avg. volume | 1,650 |
| Market cap | 462.227M |
| Beta (5Y monthly) | 1.53 |
| PE ratio (TTM) | 0.42 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
RESEARCH TRIANGLE PARK, N.C., May 14, 2024--Overall spending in the U.S. market for medicines grew by 2.5% and reached $435Bn in 2023. Excluding the contribution from COVID-19 vaccines and therapeutics, spending grew at 9.9%, according to a new report from the IQVIATM Institute for Human Data Science, The Use of Medicines in the U.S. 2024: Usage and Spending Trends and Outlook to 2028.
- Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 09, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT).
- Business Wire
IQVIA Reports First-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C., May 02, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
